Cargando…
Effects of Enzymatically Depolymerized Low Molecular Weight Heparins on CCl(4)-Induced Liver Fibrosis
With regard to identifying the effective components of LMWH drugs curing hepatic fibrosis disease, we carried out a comparative study on the efficacy of enzymatically depolymerized LMWHs on CCl(4) induced mouse liver fibrosis. The results showed that the controlled enzymatic depolymerization conditi...
Autores principales: | Yan, Yishu, Guan, Changge, Du, Shanshan, Zhu, Wenming, Ji, Yang, Su, Nan, Mei, Xiang, He, Dong, Lu, Yuan, Zhang, Chong, Xing, Xin-Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5566566/ https://www.ncbi.nlm.nih.gov/pubmed/28871223 http://dx.doi.org/10.3389/fphar.2017.00514 |
Ejemplares similares
-
NMR methods to monitor the enzymatic depolymerization of heparin
por: Limtiaco, John F. K., et al.
Publicado: (2010) -
Heparin-induced thrombocytopenia associated with low-molecular-weight heparin: clinical feature analysis of cases and pharmacovigilance assessment of the FAERS database
por: Liu, Leping, et al.
Publicado: (2023) -
On the Ability of Low Molecular Weight Chitosan Enzymatically Depolymerized to Produce and Stabilize Silver Nanoparticles
por: Aranaz, Inmaculada, et al.
Publicado: (2018) -
Identification of linderalactone as a natural inhibitor of SHP2 to ameliorate CCl(4)-induced liver fibrosis
por: Zhang, Yi, et al.
Publicado: (2023) -
Low molecular weight heparin in COVID-19: benefits and concerns
por: Makarem, Adham, et al.
Publicado: (2023)